• Partnership with NVIDIA and Nebius delivers breakthrough performance gains for molecular biology models serving critical research pipelines
 

GTC — March 2026 — Latent Labs, a leader in generative AI for molecular biology, today announced results from its deployment of NVIDIA Blackwell B300 GPUs in partnership with NVIDIA and Nebius, a leading AI cloud provider for training and inference, achieving over 4x training speedups and more than 60% faster inference for its generative models powering drug discovery.

 

As Latent Labs' increasingly sophisticated models serve a growing base of industry and academic partners across critical drug discovery pipelines, the demand for compute has scaled in parallel. To meet this moment, the company partnered with NVIDIA and Nebius to deploy its models on best-in-class NVIDIA Blackwell architecture on Nebius’s full-stack AI infrastructure.

 

The results were immediate and significant. Out of the gate, Latent Labs achieved 2–3x speedups in training workloads. With hardware-specific optimizations tailored to the Blackwell platform, those gains exceeded 4x — a step-change in the pace at which the team can develop and iterate on new models. On the inference side, NVIDIA Blackwell Server Edition GPUs delivered over 60% speedups relative to previous-generation chips, directly shortening the timelines for partners relying on Latent Labs' models in active drug discovery programs.

 

"These performance gains aren't just benchmarks, they translate directly into faster research cycles and shorter paths to therapeutic candidates for our partners," said Simon Kohl,CEO at Latent Labs. "As demand for our models grows across industry and academia, we're committed to a compute-diverse strategy that meets our partners wherever they are. Blackwell is a significant leap for the workloads we care about most, and our collaboration with NVIDIA and Nebius is an exciting part of that picture." 

 

The three teams are now looking ahead to deepen the partnership, exploring closer integration between Latent Labs' state-of-the-art generative models and NVIDIA's hardware roadmap, as well as Nebius AI Cloud for model training and inferencing, to unlock further performance gains as both the models and the platform continue to advance. “Latent Labs stands out not only for the strength of its science, but for the culture and operating model behind it. The team moves with remarkable focus and speed, and we’ve been especially impressed by the accuracy and performance of their models in production-grade research workflows. It’s exactly the kind of company we’re excited to support on Nebius AI Cloud,” says Ilya Burkov, Global Head of Healthcare and LifeSciences.

16.03.26

Latent Labs Achieves Over 4x Training Speedups on NVIDIA Blackwell GPUs, Accelerating Generative AI for Drug Discovery